Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View Plans2-year trend showing gross, operating, and net profit margins
Indraprastha Medical Corporation Ltd.'s net profit margin of 11.7% in FY2025 reflects moderate profitability, with operating margin at 16.1% and gross margin at 83.3%.
In FY 2025, Indraprastha Medical Corporation Ltd. posted a gross margin of 83.3%, an operating margin of 16.1%, a net margin of 11.7%. Gross Margin = (Revenue - COGS) / Revenue; Operating Margin = EBIT / Revenue; Net Margin = Net Income / Revenue. Typical healthy ranges: Gross 20-40%, Operating 10-20%, Net 5-10%+. Consistent or improving margins indicate strong competitive positioning.
2-year trend showing revenue, gross profit, and net profit
Indraprastha Medical Corporation Ltd.'s revenue grew 9.3% to 13.79B and net profit grew 29.9% to 1.61B YoY in FY2025, indicating moderate business momentum.
In FY 2025, Indraprastha Medical Corporation Ltd.'s revenue grew by 9.3% year-over-year. Revenue is total income from operations. Gross Profit is revenue minus cost of goods. Net Profit is the bottom line after all expenses. Consistent growth across all three signals a healthy, expanding business.
2-year trend showing shareholder returns
Indraprastha Medical Corporation Ltd.'s ROE of 27.0% in FY2025 indicates excellent capital efficiency.
In FY 2025, Indraprastha Medical Corporation Ltd. reported an ROE of 27.0%. ROE = (Net Income / Shareholders' Equity) x 100. Measures how efficiently the company turns equity into profit. Above 15% is generally strong; above 25% is excellent. Very high ROE may signal high leverage — check alongside debt levels.
2-year trend comparing profitability with cash generation
Indraprastha Medical Corporation Ltd.'s FCF/NI ratio of 0.75x in FY2025 indicates reasonable cash generation relative to profits.
In FY 2025, Indraprastha Medical Corporation Ltd.'s free cash flow trailed net income. Free Cash Flow = Operating Cash Flow - Capital Expenditure. When FCF exceeds net income, it suggests high-quality, cash-backed earnings. Persistent gaps may indicate aggressive accounting or heavy capex needs.
2-year trend comparing profitability with cash from operations
Indraprastha Medical Corporation Ltd.'s OCF/NI ratio of 0.97x in FY2025 indicates reasonable cash conversion from operations.
In FY 2025, Indraprastha Medical Corporation Ltd.'s operating cash flow trailed net income. Operating Cash Flow is the actual cash from core operations. OCF exceeding net income signals strong cash collection. OCF trailing net income may indicate aggressive revenue recognition or working capital issues.
Measure a company's financial leverage, liquidity, and ability to meet financial obligations.
2-year trend showing short-term liquidity position
Indraprastha Medical Corporation Ltd.'s current ratio of 2.41x in FY2025 indicates healthy short-term liquidity.
In FY 2025, Indraprastha Medical Corporation Ltd. reported a current ratio of 2.41. Current Ratio = Current Assets / Current Liabilities. Measures short-term liquidity. A ratio of 1.5-3.0 is generally healthy; below 1.0 signals liquidity risk; above 3.0 may indicate underutilized assets.
2-year trend showing ability to service debt
Indraprastha Medical Corporation Ltd.'s interest coverage ratio of 35.5x in FY2025 indicates comfortable debt servicing capacity.
In FY 2025, Indraprastha Medical Corporation Ltd. reported an interest coverage ratio of 35.5x. Interest Coverage = EBIT / Interest Expense. Shows how many times operating profit covers interest payments. Above 5x is comfortable; below 1.5x signals potential difficulty servicing debt.
2-year trend showing financial leverage and capital structure
Indraprastha Medical Corporation Ltd.'s debt-to-equity ratio of 0.05x in FY2025 reflects a conservative, low-leverage capital structure.
In FY 2025, Indraprastha Medical Corporation Ltd. reported a debt-to-equity ratio of 0.05. Debt-to-Equity = Total Debt / Total Equity. Below 1.0 is conservative; 1.0-2.0 is moderate; above 2.0 indicates higher financial risk. Capital-intensive industries naturally carry higher ratios.
2-year trend showing total debt with year-over-year changes
Indraprastha Medical Corporation Ltd.'s debt decreased 3.5% YoY in FY2025 — positive deleveraging improves financial flexibility.
In FY 2025, Indraprastha Medical Corporation Ltd.'s total debt decreased by 3.5% year-over-year. Total Debt includes short-term debt, long-term loans, debentures, and capital leases. YoY changes (shown as percentages) reveal whether the company is leveraging up or deleveraging.
Year-over-year change in diluted shares outstanding
Indraprastha Medical Corporation Ltd.'s diluted shares remained virtually unchanged in FY2025.
Over 2 years (FY2024–FY2025), diluted shares remained essentially unchanged at 91.68M.
In FY 2025, Indraprastha Medical Corporation Ltd.'s diluted shares decreased by 0.0% year-over-year. Diluted Shares accounts for stock options, warrants, and convertibles. Positive YoY change means dilution (red); negative means buybacks (green). Consistent dilution above 5% annually is a red flag.
You're viewing 2 years of data. Upgrade to access 10 years of financial ratios, margins, and performance metrics.
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2025